Annovis Bio ANVS

$ 4.33 -1.59%

Quarterly report 2024-Q3
added 11-08-2024

Annovis Bio Balance Sheet 2011-2024 | ANVS

Annual Balance Sheet Annovis Bio

	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
Net Debt	-	-	-	-8.07 M	-	-	-	-	-	-	-	-	-
Long Term Debt	-	-	-	-	-	-	-	-	-	-	-	-	-
Long Term Debt Current	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Current Liabilities	4.28 M	7.7 M	1.51 M	578 K	-	-	-	-	-	-	-	-	-
Total Liabilities	18 M	7.7 M	1.51 M	578 K	-	-	-	-	-	-	-	-	-
Deferred Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-
Retained Earnings	-110 M	-54.1 M	-28.7 M	-14.2 M	-	-	-	-	-	-	-	-	-
Total Assets	10.2 M	36 M	46 M	8.12 M	-	-	-	-	-	-	-	-	-
Cash and Cash Equivalents	5.75 M	28.4 M	45.7 M	8.07 M	1.86 K	-	-	-	-	-	-	-	-
Book Value	-7.75 M	28.3 M	44.5 M	7.54 M	-	-	-	-	-	-	-	-	-
Total Shareholders Equity	-7.75 M	28.3 M	44.5 M	7.54 M	-8.58 M	-	-	-	-	-	-	-	-

All numbers in USD currency

Quarterly Balance Sheet Annovis Bio

	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
Long Term Debt	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Non Current Liabilities	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	606 K	606 K	606 K	606 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Liabilities	7.3 M	6.8 M	11.2 M	18 M	3.56 M	2.07 M	5.41 M	7.7 M	2.53 M	1.3 M	1.4 M	1.51 M	1.12 M	884 K	1.6 M	578 K	578 K	578 K	578 K	2.62 M	2.62 M	2.62 M	2.62 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Deferred Revenue	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Retained Earnings	-129 M	-116 M	-111 M	-110 M	-88 M	-73.3 M	-63.8 M	-54.1 M	-46.3 M	-39.9 M	-34 M	-28.7 M	-22.8 M	-20 M	-17.4 M	-14.2 M	-14.2 M	-14.2 M	-14.2 M	-8.78 M	-8.78 M	-8.78 M	-8.78 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Assets	14.4 M	5.05 M	7.81 M	10.2 M	10.2 M	22.8 M	25.5 M	36 M	37.1 M	40 M	44.1 M	46 M	47.7 M	49.5 M	5.96 M	8.12 M	8.12 M	8.12 M	8.12 M	1.12 M	1.12 M	1.12 M	1.12 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Cash and Cash Equivalents	12.6 M	4 M	3.14 M	5.75 M	6.35 M	15.7 M	16.8 M	28.4 M	32 M	36 M	42.7 M	45.7 M	47.5 M	49.2 M	5.6 M	8.07 M	8.07 M	8.07 M	8.07 M	1.86 K	1.86 K	1.86 K	1.86 K	35.3 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Book Value	7.06 M	-1.75 M	-3.35 M	-7.75 M	6.66 M	20.7 M	20.1 M	28.3 M	34.6 M	38.7 M	42.7 M	44.5 M	46.5 M	48.6 M	4.37 M	7.54 M	7.54 M	7.54 M	7.54 M	-1.5 M	-1.5 M	-1.5 M	-1.5 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Total Shareholders Equity	7.06 M	-1.75 M	-3.35 M	-7.75 M	6.66 M	20.7 M	20.1 M	28.3 M	34.6 M	38.7 M	42.7 M	44.5 M	46.5 M	48.6 M	4.37 M	7.54 M	7.54 M	7.54 M	7.54 M	-8.58 M	-8.58 M	-8.58 M	-8.58 M	-7.59 M	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency